Donatuss - 16477-136-16 - (Dihydrocodeine Bitartrate, Phenylephrine Hydrochloride, Guaifenesin)

Alphabetical Index


Drug Information of Donatuss

Product NDC: 16477-136
Proprietary Name: Donatuss
Non Proprietary Name: Dihydrocodeine Bitartrate, Phenylephrine Hydrochloride, Guaifenesin
Active Ingredient(s): 7.5; 50; 7.5    mg/5mL; mg/5mL; mg/5mL & nbsp;   Dihydrocodeine Bitartrate, Phenylephrine Hydrochloride, Guaifenesin
Administration Route(s): ORAL
Dosage Form(s): SYRUP
Coding System: National Drug Codes(NDC)

Labeler Information of Donatuss

Product NDC: 16477-136
Labeler Name: Laser Pharmaceuticals LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED OTHER
Start Marketing Date: 20091007

Package Information of Donatuss

Package NDC: 16477-136-16
Package Description: 473 mL in 1 BOTTLE (16477-136-16)

NDC Information of Donatuss

NDC Code 16477-136-16
Proprietary Name Donatuss
Package Description 473 mL in 1 BOTTLE (16477-136-16)
Product NDC 16477-136
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Dihydrocodeine Bitartrate, Phenylephrine Hydrochloride, Guaifenesin
Dosage Form Name SYRUP
Route Name ORAL
Start Marketing Date 20091007
Marketing Category Name UNAPPROVED OTHER
Labeler Name Laser Pharmaceuticals LLC
Substance Name DIHYDROCODEINE BITARTRATE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 7.5; 50; 7.5
Strength Unit mg/5mL; mg/5mL; mg/5mL
Pharmaceutical Classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]

Complete Information of Donatuss


General Information